Vision loss in glioblastoma: Disease mimicking presumed therapeutic toxicity
- PMID: 30402261
- PMCID: PMC6213942
- DOI: 10.1093/nop/npx037
Vision loss in glioblastoma: Disease mimicking presumed therapeutic toxicity
Abstract
Glioblastoma is the most common and lethal form of primary brain cancer. In the recurrent setting, bevacizumab is a common choice for salvage therapy. Loss of vision in patients initially treated with radiation at the time of diagnosis and later treated with bevacizumab at time of recurrence has been reported, and presumed to be a treatment-related optic neuropathy. Strikingly, only 1 case report described a postmortem biopsy to rule out tumor involvement of the optic tracts. We report the first case of recurrent glioblastoma infiltrating the prechiasmatic and chiasmatic optic nerve, which at the time of vision loss was presumed to be secondary to bevacizumab. It is noteworthy that the MRI findings in the previously reported bevacizumab/radiation-induced optic neuropathy cases (without pathology follow-up) are comparable to our patient.
Keywords: Bevacizumab; Glioblastoma; Optic neuropathy; Radiation.
Figures


Similar articles
-
Radiation-Induced Optic Neuropathy: Clinical and Imaging Profile of Twelve Patients.J Neuroophthalmol. 2019 Jun;39(2):170-180. doi: 10.1097/WNO.0000000000000670. J Neuroophthalmol. 2019. PMID: 30113934
-
Glioblastoma multiforme mimicking optic neuritis.Am J Ophthalmol Case Rep. 2020 Jan 7;17:100594. doi: 10.1016/j.ajoc.2020.100594. eCollection 2020 Mar. Am J Ophthalmol Case Rep. 2020. PMID: 32395666 Free PMC article.
-
Transtentorial dissemination of optic nerve glioblastoma: case report.J Neurosurg. 2018 Feb;128(2):406-413. doi: 10.3171/2016.10.JNS161443. Epub 2017 Feb 17. J Neurosurg. 2018. PMID: 28298017
-
The role of bevacizumab in the treatment of glioblastoma.J Neurooncol. 2017 Jul;133(3):455-467. doi: 10.1007/s11060-017-2477-x. Epub 2017 May 19. J Neurooncol. 2017. PMID: 28527008 Review.
-
Drug review: Safety and efficacy of bevacizumab for glioblastoma and other brain tumors.Jpn J Clin Oncol. 2013 Jun;43(6):587-95. doi: 10.1093/jjco/hyt051. Epub 2013 Apr 12. Jpn J Clin Oncol. 2013. PMID: 23585688 Review.
Cited by
-
Gliomatosis cerebri with blindness: A case report with literature review.Radiol Case Rep. 2023 Jun 15;18(9):2884-2894. doi: 10.1016/j.radcr.2023.05.037. eCollection 2023 Sep. Radiol Case Rep. 2023. PMID: 37388536 Free PMC article.
References
-
- Parsons JT, Bova FJ, Fitzgerald CR et al. . Radiation optic neuropathy after megavoltage external-beam irradiation: analysis of time-dose factors. Int J Radiat Oncol Biol Phys. 1994;30(4):755–763. - PubMed
-
- Bhandare N, Monroe AT, Morris CG et al. . Does altered fractionation influence the risk of radiation-induced optic neuropathy?Int J Radiat Oncol Biol Phys. 2005;62(4):1070–1077. - PubMed
-
- Kelly PJ, Dinkin MJ, Drappatz J et al. . Unexpected late radiation neurotoxicity following bevacizumab use: a case series. J Neurooncol. 2011;102(3):485–490. - PubMed